TrialInvestigational new drugs2021

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.

Daisuke Kotani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.